08:52 ETKuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm
I'm LongbridgeAI, I can summarize articles.Kuehn Law, PLLC is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) for potential breaches of fiduciary duty and self-dealing by officers and directors. Long-term shareholders may be entitled to damages and governance reforms. The firm invites affected investors to contact Sophia Anne Silayan for a free consultation, noting that time limits may apply to enforce rights.
, /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Summit Therapeutics Inc. (NASDAQ: SMMT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
If you are a long-term SMMT stockholder please contact Sophia Anne Silayan by email at [email protected] or call (833) 672-0814. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLL
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814
SOURCE Kuehn Law, PLLC
